作者：
Renee Maria,Saliby [1]
;
Talal,El Zarif [1]
;
Ziad,Bakouny [2]
;
Valisha,Shah [1]
;
Wanling,Xie [3]
;
Ronan,Flippot [4]
;
Thomas,Denize [5]
;
M Harry,Kane [6]
;
Katrine N,Madsen [6]
;
Miriam,Ficial [5]
;
Laure,Hirsch [1]
;
Xiao X,Wei [1]
;
John A,Steinharter [7]
;
Lauren C,Harshman [8]
;
Ulka N,Vaishampayan [9]
;
Mariano,Severgnini [10]
;
David F,McDermott [11]
;
Gwo-Shu Mary,Lee [1]
;
Wenxin,Xu [1]
;
Eliezer M,Van Allen [1]
;
Bradley A,McGregor [1]
;
Sabina,Signoretti [5]
;
Toni K,Choueiri [1]
;
Rana R,McKay [12]
;
David A,Braun [13]
作者单位：
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
[1]
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.;Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
[2]
Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
[3]
Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France.
[4]
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
[5]
Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, Connecticut.
[6]
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.;Larner College of Medicine, University of Vermont, Burlington, Vermont.
[7]
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.;Surface Oncology, Cambridge, Massachusetts.
[8]
University of Michigan/Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
[9]
Center for Immuno-Oncology Immune Assessment Laboratory at the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
[10]
Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
[11]
Moores Cancer Center, University of California San Diego, La Jolla, California.
[12]
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.;Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, Connecticut.
[13]
DOI
10.1158/2326-6066.CIR-22-0996
PMID
37279009
发布时间
2024-09-26
换一批
换一批
